Abstract
EBNA 3C is one of only nine proteins expressed by the tumourigenic γ-herpesvirus Epstein-Barr virus (EBV) during the infection and immortalization of human B lymphocytes. In fact, the expression of EBNA 3C has been shown to be essential for the B-cell transformation process to take place. The mechanism by which EBNA 3C contributes to viral pathogenicity has therefore been the subject of intensive research over many years. The first clues on the function of EBNA 3C came from analysis of the primary amino acid sequence of EBNA 3C which identified a number of domains commonly found in transcriptional regulatory proteins. These domains include a proline-rich and a glutamine-proline-rich domain and a putative bZIP domain located in the N-terminus of the protein. EBNA 3C has subsequently been shown to function as a regulator of both viral and cellular transcription and to have potent effects on normal cell-cycle regulatory pathways. This review will discuss our current knowledge of the functions of EBNA 3C, the roles played by the different domains of EBNA 3C in these functions, and summarize some recent work from our laboratory that provides the first structural and functional analysis of the putative bZIP domain of EBNA 3C.
Keywords: EBV, transcription, EBNA 3C, bZIP, structure, domains, cell-cycle, RBP-Jk
Current Protein & Peptide Science
Title: Structure and Function of the Epstein-Barr Virus Transcription Factor, EBNA 3C
Volume: 7 Issue: 2
Author(s): Michelle J. West
Affiliation:
Keywords: EBV, transcription, EBNA 3C, bZIP, structure, domains, cell-cycle, RBP-Jk
Abstract: EBNA 3C is one of only nine proteins expressed by the tumourigenic γ-herpesvirus Epstein-Barr virus (EBV) during the infection and immortalization of human B lymphocytes. In fact, the expression of EBNA 3C has been shown to be essential for the B-cell transformation process to take place. The mechanism by which EBNA 3C contributes to viral pathogenicity has therefore been the subject of intensive research over many years. The first clues on the function of EBNA 3C came from analysis of the primary amino acid sequence of EBNA 3C which identified a number of domains commonly found in transcriptional regulatory proteins. These domains include a proline-rich and a glutamine-proline-rich domain and a putative bZIP domain located in the N-terminus of the protein. EBNA 3C has subsequently been shown to function as a regulator of both viral and cellular transcription and to have potent effects on normal cell-cycle regulatory pathways. This review will discuss our current knowledge of the functions of EBNA 3C, the roles played by the different domains of EBNA 3C in these functions, and summarize some recent work from our laboratory that provides the first structural and functional analysis of the putative bZIP domain of EBNA 3C.
Export Options
About this article
Cite this article as:
West J. Michelle, Structure and Function of the Epstein-Barr Virus Transcription Factor, EBNA 3C, Current Protein & Peptide Science 2006; 7 (2) . https://dx.doi.org/10.2174/138920306776359777
DOI https://dx.doi.org/10.2174/138920306776359777 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein Interaction Domains: Structural Features and Drug Discovery Applications (Part 2)
Current Medicinal Chemistry CD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Chromosomal Aberrations and Genomic Instability Induced by Topoisomerase- Targeted Antitumour Drugs
Current Medicinal Chemistry - Anti-Cancer Agents Radiofrequency Radiation and Human Triiodothronine Hormone: Immunoenzymometric Assay
Recent Patents on Biomarkers Interactions Between Nanosized Materials and the Brain
Current Medicinal Chemistry The Evaluation of Animal Models in the Development of Anticancer Agents: From Preclinical to Clinical Tests
Current Cancer Drug Targets Detection of Tumor Markers with ProteinChip® Technology
Current Pharmaceutical Biotechnology Anti-Cancer Effects of a New Docosahexaenoic Acid Monoacylglyceride in Lung Adenocarcinoma
Recent Patents on Anti-Cancer Drug Discovery Erythropoietin and Oxidative Stress
Current Neurovascular Research Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors
Current Cancer Drug Targets Human Carbonyl Reductases
Current Drug Metabolism Advances in Methods for Therapeutic Peptide Discovery, Design and Development
Current Pharmaceutical Biotechnology Tyrosine Kinase Update: Role and Response in Cancer Therapy
Current Cancer Therapy Reviews Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Current Pharmaceutical Biotechnology Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Current Pharmaceutical Design Syntheses of 2,3-Diarylated 2H-Benzo[e][1,2]Thiazine 1,1-Dioxides and their 3,4-Dihydro Derivatives, and Assessment of their Inhibitory Activity Against MCF-7 Breast Cancer Cells
Medicinal Chemistry AFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species
Current Pharmaceutical Design Applications of Gene Transfer to Targeted Radiotherapy
Current Pharmaceutical Design Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy
Current Pharmaceutical Biotechnology